Signal2026-03-16
ClinicalTrials.gov

[PHASE3] ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency

Part of

Precision Diagnostics And Screening Innovations

Open primary sourceSee the whole picture